Active Ingredient⁚ Desvenlafaxine Succinate
Description for Pristiq. Containing desvenlafaxine succinate, Pristiq is used to treat major depressive disorder. Desvenlafaxine, the active ingredient, is a metabolite of venlafaxine, another antidepressant.
Inactive Ingredients
For Pristiq, the inactive ingredients in the 25 mg and 50 mg tablets include hypromellose٫ microcrystalline cellulose٫ talc٫ magnesium stearate٫ and a film coating made up of polyvinyl alcohol٫ polyethylene glycol٫ talc٫ titanium dioxide٫ and iron oxides.
25 mg and 50 mg Tablets
Pristiq tablets are available in 25 mg and 50 mg strengths. The 25 mg and 50 mg tablets contain the active ingredient desvenlafaxine succinate. In addition to desvenlafaxine succinate, the tablets contain various inactive ingredients, including hypromellose, microcrystalline cellulose, talc, magnesium stearate, and a film coating composed of polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide, and iron oxides.
Excipients/Inactive Ingredients
For Pristiq, the inactive ingredients in the 50 mg tablet consist of hypromellose, microcrystalline cellulose, talc, magnesium stearate, and film coating, which consists of polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide, and iron oxides.
Dosage Form / Strength Nonmedicinal Ingredients
Oral PRISTIQ is an extended-release tablet containing 50 and 100 mg desvenlafaxine as desvenlafaxine succinate. The nonmedicinal ingredients include hypromellose٫ magnesium stearate٫ microcrystalline cellulose٫ talc٫ and a film coating consisting of polyvinyl alcohol٫ titanium dioxide٫ and polyethylene glycol.
Common Side Effects
Common Pristiq side effects may include dizziness, drowsiness, anxiety, increased sweating, nausea, decreased appetite, constipation, sleep problems, and sexual dysfunction. It is essential to monitor and report any unusual symptoms to your healthcare provider while taking Pristiq.
Important Information
PRISTIQ should not be taken if allergic to desvenlafaxine, venlafaxine, or any ingredients in PRISTIQ. It is important to consult a doctor for further information or concerns regarding this medication. Avoid taking PRISTIQ if currently using MAOIs or related medications.
Summary
Pristiq contains the active ingredient desvenlafaxine succinate, an SNRI used for treating major depressive disorder. Inactive ingredients in the 25 mg and 50 mg tablets include hypromellose, microcrystalline cellulose, talc, magnesium stearate, and a film coating comprising polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide, and iron oxides. Common side effects may include dizziness, drowsiness, anxiety, sweating, nausea, decreased appetite, constipation, sleep disturbances, and sexual dysfunction. It is crucial not to take Pristiq if allergic to desvenlafaxine or venlafaxine and to consult a healthcare provider for concerns. Avoid use with MAOIs or related medications.
10 responses to “Ingredients of Pristiq”
The presence of talc in the tablets may raise concerns for individuals who are sensitive or allergic to this particular ingredient.
It
The list of inactive ingredients in Pristiq tablets provides important information for individuals with specific allergies.
Understanding the inactive ingredients in medications like Pristiq is crucial for healthcare professionals when considering treatment options.
Patients should always consult with their healthcare provider to discuss any concerns regarding the ingredients in their prescribed medications.
Overall, the detailed breakdown of active and inactive ingredients in Pristiq enhances transparency and understanding for consumers.
The combination of these active and inactive ingredients in Pristiq showcases the complexity of modern pharmaceutical formulations.
The film coating composition of polyvinyl alcohol and polyethylene glycol is commonly used in pharmaceuticals for various purposes.
The inclusion of hypromellose, microcrystalline cellulose, and magnesium stearate in the tablets shows attention to detail in formulation.
The description of Pristiq containing desvenlafaxine succinate for treating major depressive disorder is informative.